Ondine Biomedical (FRA:VF5) Total Liabilities : €2.72 Mil (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Ondine Biomedical Total Liabilities?

Ondine Biomedical's Total Liabilities for the quarter that ended in Jun. 2024 was €2.72 Mil.

Ondine Biomedical's quarterly Total Liabilities increased from Jun. 2023 (€2.27 Mil) to Dec. 2023 (€2.49 Mil) and increased from Dec. 2023 (€2.49 Mil) to Jun. 2024 (€2.72 Mil).

Ondine Biomedical's annual Total Liabilities increased from Dec. 2021 (€3.10 Mil) to Dec. 2022 (€3.42 Mil) but then declined from Dec. 2022 (€3.42 Mil) to Dec. 2023 (€2.49 Mil).

Ondine Biomedical Total Liabilities Historical Data

The historical data trend for Ondine Biomedical's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ondine Biomedical Total Liabilities Chart

Ondine Biomedical Annual Data

Trend

Dec08

Dec09

Dec10

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

19.81

23.40

3.10

3.42

2.49

Ondine Biomedical Semi-Annual Data
	Dec07	Jun08	Dec08	Jun09	Dec09	Jun10	Dec10	Jun11	Dec17	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Total Liabilities	Get a 7-Day Free Trial															2.58	3.42	2.27	2.49	2.72

Ondine Biomedical Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Ondine Biomedical's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	2.385	+	(0.109	+	4.3021142204225E-16
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	2.49

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	3.919	-	1.425
	=	2.49

Ondine Biomedical's Total Liabilities for the quarter that ended in Jun. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	2.715	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	2.72

Total Liabilities	=	Total Assets (Q: Jun. 2024 )	-	Total Equity (Q: Jun. 2024 )
	=	2.728	-	0.013
	=	2.72

Ondine Biomedical Total Liabilities Related Terms

Thank you for viewing the detailed overview of Ondine Biomedical's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Ondine Biomedical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ondine Biomedical Inc (FRA:VF5) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

OBIMF:USA OBI:UK

Address

1100 Melville Street, Suite 888, Vancouver, BC, CAN, V6E4A6

Website

https://www.ondinebio.com

Ondine Biomedical Inc is a life sciences company, focusing on the development of photodisinfection-based therapies to provide solutions to drug-resistant infections. The company has created a platform technology called antimicrobial photodynamic disinfection, or photodisinfection, to help prevent and help treat infections across different therapeutic areas in healthcare and industry settings. Canada is the major revenue generator for the group. The company has one reportable operating segment that is antimicrobial photodynamic therapy (aPDT) products.

Ondine Biomedical Headlines

No Headlines